15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Pharvaris BV, 9 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $30.00 to $75.00 (about 2.5x), a sign of real disagreement on valuation. The average target of $49.20 sits 30% above the current $37.75. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.72 next quarter toward $-2.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Strong Buy
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Pharvaris BV.
As of Sep, 9 of 10 firms rate PHVS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PHVS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.72
Range $-0.90 – $-0.62 · 11 analysts · +1% YoY
Next period, 11 analysts expect Pharvaris BV to earn $-0.72 a share (range $-0.90 – $-0.62), versus $-0.71 a year earlier. Full-year consensus is $-2.77, growing to $-2.67 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 11 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $30.2M next year.
Top analysts covering Pharvaris BV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PHVS.
#1
Jonathan Wolleben
JMP Securities · Rank #29
Buy
$74.00+96.0% to target
Overall win rate
47%
+ Follow
#2
Laura Chico
Wedbush · Rank #74
Buy
$42.00+11.3% to target
Overall win rate
44%
+ Follow
#3
Debjit Chattopadhyay
Guggenheim · Rank #113
Buy
$40.00+6.0% to target
Overall win rate
44%
+ Follow
#4
Patrick R. Trucchio
HC Wainwright & Co. · Rank #230
Buy
$60.00+58.9% to target
Overall win rate
36%
+ Follow
#5
Jeff Jones
Oppenheimer · Rank #247
Buy
$50.00+32.5% to target
Overall win rate
31%
+ Follow
PHVS stock forecast FAQ
What is PHVS's average 12-month price target?+
The 10 analysts with a live target average $49.20 for Pharvaris BV over the next 12 months, ranging from a $75.00 high to a $30.00 low.
Is PHVS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PHVS?+
The Street-high target is $75.00 (Citizens), and the Street-low is $30.00 (B of A Securities). The average of all 10 active targets is $49.20.
How many Wall Street analysts cover PHVS?+
10 analysts have an active rating on Pharvaris BV, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering PHVS?+
Among analysts who currently cover PHVS, Jonathan Wolleben of JMP Securities has the strongest overall Quantellect track record (Rank #29). Their current call is Buy with a $74.00 target.
What is Pharvaris BV's projected EPS for next quarter?+
The consensus estimate is $-0.72 per share (range $-0.90 – $-0.62) across 11 analysts. Full-year EPS is projected at $-2.77, rising to $-2.67 the following year.
How much revenue is Pharvaris BV expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $30.2M next year.
Have analysts been upgrading or downgrading PHVS lately?+
As of Sep, 9 of 10 firms rate PHVS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PHVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
